{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:31:37Z","timestamp":1793014297344,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.semperi.2024.152009","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T15:35:35Z","timestamp":1732289735000},"page":"152009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pre-natal and post-natal screening and testing in neonatal abstinence syndrome"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7452-3486","authenticated-orcid":false,"given":"Sharon","family":"Ostfeld-Johns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semperi.2024.152009_bib0001","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/ALN.0000000000000472","article-title":"Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes","volume":"121","author":"Maeda","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.semperi.2024.152009_bib0002","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.drugalcdep.2017.01.003","article-title":"Non-medical opioid use and sources of opioids among pregnant and non-pregnant reproductive-aged women","volume":"174","author":"Kozhimannil","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.semperi.2024.152009_bib0003","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11920-015-0626-5","article-title":"Substance use in the perinatal period","volume":"17","author":"Forray","year":"2015","journal-title":"Curr Psychiatry Rep"},{"issue":"8","key":"10.1016\/j.semperi.2024.152009_bib0004","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10995-010-0720-6","article-title":"Universal alcohol\/drug screening in prenatal care: a strategy for reducing racial disparities? Questioning the assumptions","volume":"15","author":"Roberts","year":"2011","journal-title":"Matern Child Health J"},{"issue":"2","key":"10.1016\/j.semperi.2024.152009_bib0005","first-page":"86","article-title":"Epidemiology of perinatal substance use: exploring trends in maternal substance use","volume":"24","author":"Rodriguez","year":"2019","journal-title":"Perinatal Substance USE"},{"issue":"2","key":"10.1016\/j.semperi.2024.152009_bib0006","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1575","article-title":"Families affected by parental substance use","volume":"138","author":"Smith","year":"2016","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.semperi.2024.152009_bib0007","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamapediatrics.2020.1622","article-title":"Associations of maternal prenatal drug abuse with measures of newborn brain structure, tissue organization, and metabolite concentrations","volume":"174","author":"Peterson","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.semperi.2024.152009_bib0008","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.publhealth.18.1.463","article-title":"The effects of poverty on child health and development","volume":"18","author":"Aber","year":"1997","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.semperi.2024.152009_bib0009","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1196\/annals.1425.016","article-title":"Poverty, maternal health, and adverse pregnancy outcomes","volume":"1136","author":"Nagahawatte","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.semperi.2024.152009_bib0010","doi-asserted-by":"crossref","unstructured":"Larson CP. Poverty during pregnancy: Its effects on child health outcomes. Paediatr Child Health. 2007 Oct;12(8):673\u20137. doi: 10.1093\/pch\/12.8.673. PMID: 19030445; PMCID: PMC2528810.","DOI":"10.1093\/pch\/12.8.673"},{"issue":"2","key":"10.1016\/j.semperi.2024.152009_bib0011","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1753495x12473751","article-title":"Effects of prenatal stress on pregnancy and human development: mechanisms and pathways","volume":"6","author":"ME","year":"2013","journal-title":"Obstet Med"},{"issue":"4","key":"10.1016\/j.semperi.2024.152009_bib0012","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.9244","article-title":"Association of elevated maternal psychological distress, altered fetal brain, and offspring cognitive and social-emotional outcomes at 18 months","volume":"5","author":"Wu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.semperi.2024.152009_bib0013","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41386-023-01765-3","article-title":"The effects of experience of discrimination and acculturation during pregnancy on the developing offspring brain","volume":"49","author":"Spann","year":"2024","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.semperi.2024.152009_bib0014","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-023-06043-0","article-title":"Associations between neighborhood stress and maternal sex steroid hormones in pregnancy","volume":"23","author":"Hansel","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"issue":"4","key":"10.1016\/j.semperi.2024.152009_bib0015","article-title":"Poverty and child health in the united states","volume":"137","author":"Gitterman","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.semperi.2024.152009_bib0016","unstructured":"The White House Executive Office of the President, Office of National Drug Control Policy. (2024d, May 14). Substance use disorder in pregnancy: IMPROVING OUTCOMES FOR FAMILIES. https:\/\/www.whitehouse.gov\/wp-content\/uploads\/2021\/10\/ONDCP_Report-Substance-Use-Disorder-and-Pregnancy.pdf."},{"key":"10.1016\/j.semperi.2024.152009_bib0017","volume":"809","author":"Bach","year":"2019"},{"issue":"3","key":"10.1016\/j.semperi.2024.152009_bib0018","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-0128","article-title":"Prenatal opioid exposure: neurodevelopmental consequences and future research priorities","volume":"144","author":"Conradt","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.semperi.2024.152009_bib0019","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2015.02.027","article-title":"Perinatal substance use: a prospective evaluation of abstinence and relapse","volume":"150","author":"Forray","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.semperi.2024.152009_bib0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12889-019-6455-4","article-title":"Levels and predictors of participation in integrated treatment programs for pregnant and parenting women with problematic substance use","volume":"19","author":"Le","year":"2019","journal-title":"BMC Public Health"},{"issue":"5","key":"10.1016\/j.semperi.2024.152009_bib0021","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1097\/ADM.0000000000000647","article-title":"Recovery from opioid use disorder (OUD) after monthly long-acting buprenorphine treatment: 12-month longitudinal outcomes from recover, an observational study","volume":"14","author":"Ling","year":"2020","journal-title":"J Addict Med"},{"issue":"2","key":"10.1016\/j.semperi.2024.152009_bib0022","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/ANS.0000000000000118","article-title":"The mothering experiences of women with substance use disorders","volume":"39","author":"Cleveland","year":"2016","journal-title":"Adv Nurs Sci"},{"issue":"1","key":"10.1016\/j.semperi.2024.152009_bib0023","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/15271544211067781","article-title":"Social construction of target populations: a theoretical framework for understanding policy approaches to perinatal illicit substance screening policy","volume":"23","author":"Cooper","year":"2022","journal-title":"Politics & Nursing Practice"},{"key":"10.1016\/j.semperi.2024.152009_bib0024","doi-asserted-by":"crossref","first-page":"e2221","DOI":"10.1002\/icd.2221","article-title":"The role of mother's prenatal substance use disorder and early parenting on child social cognition at school age","volume":"30","author":"Flykt","year":"2021","journal-title":"Inf Child Dev"},{"key":"10.1016\/j.semperi.2024.152009_bib0025","series-title":"Best Interest of the Child Standard in Connecticut","year":"2024"},{"key":"10.1016\/j.semperi.2024.152009_bib0026","first-page":"523","volume":"43","author":"Trivedi","year":"2019"},{"key":"10.1016\/j.semperi.2024.152009_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110944","article-title":"Outcomes and experiences after child custody loss among mothers who use drugs: A mixed studies systematic review","volume":"251","author":"Darlington","year":"2023","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.semperi.2024.152009_bib0028","series-title":"Abusive Policies: How the American Child Welfare System Lost Its Way","author":"Raz","year":"2020"},{"key":"10.1016\/j.semperi.2024.152009_bib0029","series-title":"Torn Apart: How the Child Welfare System Destroys Black Families\u2013And How Abolition Can Build a Safer World","author":"Roberts","year":"2022"},{"key":"10.1016\/j.semperi.2024.152009_bib0030","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.ajog.2019.03.022","volume":"221","author":"Ecker","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.semperi.2024.152009_bib0031","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4070","article-title":"Committee on Substance Use and Prevention. A public health response to opioid use in pregnancy","volume":"139","author":"Patrick","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.semperi.2024.152009_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107651","article-title":"Identification of substance use disorders among pregnant women: A comparison of screeners","volume":"205","author":"Chang","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.semperi.2024.152009_bib0033","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.amjmed.2015.02.007","article-title":"A brief patient self-administered substance use screening tool for primary care: two-site validation study of the substance use brief screen (SUBS)","volume":"128","author":"McNeely","year":"2015","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.semperi.2024.152009_bib0034","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s10995-021-03127-1","article-title":"Improved maternal and infant outcomes with serial, self-reported early prenatal substance use screening","volume":"25","author":"Boden","year":"2021","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.semperi.2024.152009_bib0035","series-title":"Appropriate Use of Drug Testing in Clinical Addiction Medicine (Consensus Statement of the American Society of Addiction Medicine","author":"Jarvis","year":"2017"},{"key":"10.1016\/j.semperi.2024.152009_bib0036","series-title":"Urine Toxicology Test of the Pregnant Patient","year":"2023"},{"issue":"6","key":"10.1016\/j.semperi.2024.152009_bib0037","first-page":"e417","article-title":"False-positive fentanyl urine detection after initiation of labetalol treatment for hypertension in pregnancy: a case report","volume":"16","author":"Wanar","year":"2022","journal-title":"J Addict Med"},{"issue":"2 PART 2","key":"10.1016\/j.semperi.2024.152009_bib0038","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/AOG.0b013e318206c07c","article-title":"False-positive amphetamine toxicology screen results in three pregnant women using labetalol","volume":"117","author":"Yee","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.semperi.2024.152009_bib0039","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jogn.2022.10.002","article-title":"Drug testing practices and policies of labor and delivery units across the southeastern United States","volume":"52","author":"Byrd","year":"2023","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"4","key":"10.1016\/j.semperi.2024.152009_bib0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1542\/hpeds.2022-006897","article-title":"Limited utility of toxicology testing at delivery for perinatal cannabis use","volume":"13","author":"Sarathy","year":"2023","journal-title":"Hosp Pediatr"},{"issue":"6","key":"10.1016\/j.semperi.2024.152009_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100733","article-title":"Urine drug screening on labor and delivery","volume":"4","author":"Chin","year":"2022","journal-title":"Am J Obstetrics Gynecol MFM"},{"issue":"3","key":"10.1016\/j.semperi.2024.152009_bib0042","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/journalofethics.2018.20.3.msoc1-1803","article-title":"When Should Screening and Surveillance Be Used during Pregnancy?","volume":"20","author":"Campbell","year":"2018","journal-title":"AMA J Ethics"},{"key":"#cr-split#-10.1016\/j.semperi.2024.152009_bib0043.1","unstructured":"Ferguson v. City of Charleston, 532 U.S. 67 (2001)"},{"key":"#cr-split#-10.1016\/j.semperi.2024.152009_bib0043.2","unstructured":"Id. on remand, 308 F.3d 380 (4th Cir. 2002)."},{"key":"10.1016\/j.semperi.2024.152009_bib0044","unstructured":"American College of Obstetricians and Gynecologists. (2015). Toolkit on state legislation - pregnant women & prescription drug abuse, dependence and addiction. https:\/\/www.astho.org\/globalassets\/pdf\/state-legislation-toolkit-pregnant-women-prescription-drug-abuse-dependence-addiction.pdf."},{"key":"10.1016\/j.semperi.2024.152009_bib0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/jwh.2006.0070","article-title":"The effect of race on provider decisions to test for illicit drug use in the peripartum setting","volume":"16","author":"Kunins","year":"2007","journal-title":"J Women's Heal"},{"key":"10.1016\/j.semperi.2024.152009_bib0046","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/AOG.0000000000003986","article-title":"Toxicology testing in pregnancy: evaluating the role of social profiling","volume":"136","author":"Perlman","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.semperi.2024.152009_bib0047","first-page":"1169","article-title":"Racial inequities in drug tests ordered by clinicians for pregnant people who disclose prenatal substance use","volume":"142","author":"Olaniyan","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.semperi.2024.152009_bib0048","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.acap.2023.01.012","article-title":"Disparities in maternal-infant drug testing, social work assessment, and custody at 5 hospitals","volume":"23","author":"Cohen","year":"2023","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.semperi.2024.152009_bib0049","doi-asserted-by":"crossref","DOI":"10.1080\/10550887.2024.2391156","article-title":"Implications of xylazine exposure in pregnancy: a narrative review","author":"Hull","year":"2024","journal-title":"J Addict Dis"},{"key":"10.1016\/j.semperi.2024.152009_bib0050","series-title":"Pregnancy and Substance use: A harm Reduction Toolkit","year":"2023"},{"key":"10.1016\/j.semperi.2024.152009_bib0051","series-title":"SAMHSA's Working Definition of Recovery","year":"2012"},{"key":"10.1016\/j.semperi.2024.152009_bib0052","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/FTD.0000000000000724","article-title":"Pregnancy alters CYP- and UGT-mediated metabolism of buprenorphine","volume":"42","author":"Zhang","year":"2020","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.semperi.2024.152009_bib0053","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/ADM.0000000000000398","article-title":"The use of serum methadone\/metabolite ratios to monitor changing perinatal pharmacokinetics","volume":"12","author":"McCarthy","year":"2018","journal-title":"J Addict Med"},{"issue":"2","key":"10.1016\/j.semperi.2024.152009_bib0054","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semperi.2024.152009_bib0055","series-title":"Medications For Opioid Use Disorder: For Healthcare and Addiction Professionals, Policymakers, Patients, and Families. Treatment Improvement Protocol 63","year":"2021"},{"issue":"3","key":"10.1016\/j.semperi.2024.152009_bib0056","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/jamapsychiatry.2023.4523","article-title":"Pregnancy and postpartum drug overdose deaths in the us before and during the COVID-19 pandemic","volume":"81","author":"Han","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.semperi.2024.152009_bib0057","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/ADM.0000000000000308","article-title":"Treating women who are pregnant and parenting for opioid use disorder and the concurrent care of their infants and children: literature review to support national guidance","volume":"11","author":"Klaman","year":"2017","journal-title":"J Addict Med"},{"issue":"8","key":"10.1016\/j.semperi.2024.152009_bib0058","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1542\/hpeds.2018-0227","article-title":"Increased severity of neonatal abstinence syndrome associated with concomitant antenatal opioid and benzodiazepine exposure","volume":"9","author":"Sanlorenzo","year":"2019","journal-title":"Hosp Pediatr"},{"issue":"11","key":"10.1016\/j.semperi.2024.152009_bib0059","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111327","article-title":"Neonatal adaptation in infants prenatally exposed to antidepressants- clinical monitoring using neonatal abstinence score","volume":"9","author":"Forsberg","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.semperi.2024.152009_bib0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0145-2134(96)00014-2","article-title":"The developmental outcome of children born to heroin-dependent mothers, raised at home or adopted","volume":"20","author":"Ornoy","year":"1996","journal-title":"Child Abuse Negl"},{"issue":"5","key":"10.1016\/j.semperi.2024.152009_bib0061","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1542\/peds.2015-0699","article-title":"Hospital stay for healthy term newborn infants","volume":"135","author":"Benitz","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.semperi.2024.152009_bib0062","series-title":"(NICE Clinical Guidelines, No. 52.) 5, ASSESSMENT AND TESTING","article-title":"Drug misuse: opioid detoxification","year":"2008"},{"issue":"4","key":"10.1016\/j.semperi.2024.152009_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2021.100366","article-title":"Concordance and discordance between maternal and newborn drug test results","volume":"3","author":"Mark","year":"2021","journal-title":"Am J Obstet. Gynecol MFM"},{"key":"10.1016\/j.semperi.2024.152009_bib0064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2022.11.002","article-title":"Drug testing in support of the diagnosis of neonatal abstinence syndrome: The current situation","volume":"111","author":"Langman","year":"2023","journal-title":"Clin Biochem"},{"key":"10.1016\/j.semperi.2024.152009_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.1071564","article-title":"Toxicology as a diagnostic tool to identify the misuse of drugs in the perinatal period","volume":"10","author":"Jones","year":"2023","journal-title":"Front Pediatr"},{"issue":"7","key":"10.1016\/j.semperi.2024.152009_bib0066","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/clinchem\/hvae018","article-title":"Biological Testing and interpretation of laboratory results associated with detecting newborns with substance exposure","volume":"70","author":"McMillin","year":"2024","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.semperi.2024.152009_bib0067","first-page":"233","article-title":"Racial disparities in newborn drug testing after implementation of question-based screening for prenatal substance use","volume":"144","author":"Soos","year":"2024","journal-title":"Obstetrics Gynecol"},{"key":"10.1016\/j.semperi.2024.152009_bib0068","series-title":"Oral abstract, Pediatric Academic Societies Conference","article-title":"Reducing use of newborn toxicology tests to improve health equity","author":"Ostfeld-Johns","year":"2023"},{"issue":"1","key":"10.1016\/j.semperi.2024.152009_bib0069","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-9120(88)80113-9","article-title":"Timing of specimen collection is crucial in urine screening of drug dependent mothers and newborns","volume":"21","author":"Halstead","year":"1988","journal-title":"Clin Biochem"},{"issue":"2","key":"10.1016\/j.semperi.2024.152009_bib0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/jat\/bkad085","article-title":"High-sensitivity neonatal urine drug testing has similar positivity rates to meconium for detecting in utero exposure to methamphetamine and cocaine","volume":"48","author":"Brown","year":"2024","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.semperi.2024.152009_bib0071","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jpeds.2021.12.021","article-title":"Standardizing the clinical definition of opioid withdrawal in the neonate","volume":"243","author":"Jilani","year":"2022","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.semperi.2024.152009_bib0072","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jamapediatrics.2018.5029","article-title":"Pharmacologic Treatment for neonatal abstinence syndrome: which medication is best?","volume":"173","author":"Wachman","year":"2019","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.semperi.2024.152009_bib0073","unstructured":"consensus clinical guidelines for management of neonatal opioid withdrawal syndrome (nows) & drug exposed infants: ucsf northern california neonatal consortium (ncnc) originated 12\/2013. Last revised 7\/2019, 9\/2023. Accessed online October 25, 2024 at: https:\/\/medconnection.ucsfbenioffchildrens.org\/news\/consensus-guidelines-for-management-of-neonatal-opioid-withdrawal-syndrome-nows-and-drug-exposed-infants#section1."},{"issue":"2","key":"10.1016\/j.semperi.2024.152009_bib0074","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1542\/peds.107.2.309","article-title":"The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report","volume":"107","author":"Lester","year":"2001","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.semperi.2024.152009_bib0075","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1701-2163(16)34150-0","article-title":"Alcohol and drug screening of newborns: would women consent?","volume":"31","author":"Hicks","year":"2009","journal-title":"J Obstet Gynecol Can JOGC"},{"issue":"2","key":"10.1016\/j.semperi.2024.152009_bib0076","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/ijns9020026","article-title":"Information and parental consent for french neonatal screening: a qualitative study on parental opinion","volume":"9","author":"Pinel","year":"2023","journal-title":"Int J Neonatal Screen"},{"issue":"3","key":"10.1016\/j.semperi.2024.152009_bib0077","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.alcohol.2011.09.029","article-title":"Neonatal screening for prenatal alcohol exposure: Assessment of voluntary maternal participation in an open meconium screening program","volume":"46","author":"Zelner","year":"2012","journal-title":"Alcohol"},{"issue":"10","key":"10.1016\/j.semperi.2024.152009_bib0078","first-page":"676","article-title":"Limiting parents\u2019 rights in medical decision making","volume":"8","author":"Black","year":"2006","journal-title":"Am Med Assocn J Ethics Virtual Mentor"},{"issue":"4","key":"10.1016\/j.semperi.2024.152009_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2021.100366","article-title":"Concordance and discordance between maternal and newborn drug test results","volume":"3","author":"Mark","year":"2021","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.semperi.2024.152009_bib0080","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000001322","article-title":"Drug Testing interpretation in the peripartum setting: results of clinician survey","author":"Kurtz","year":"2024","journal-title":"J Addict Med"},{"key":"10.1016\/j.semperi.2024.152009_bib0081","doi-asserted-by":"crossref","first-page":"e1379","DOI":"10.1542\/peds.2008-3525","article-title":"Infant race affects application of clinical guidelines when screening for drugs of abuse in newborns","volume":"125","author":"Ellsworth","year":"2010","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.semperi.2024.152009_bib0082","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1542\/hpeds.2020-005765","article-title":"Toxicology Testing in a newborn icu: does social profiling play a role?","volume":"11","author":"Perlman","year":"2021","journal-title":"Hosp Pediatr"},{"key":"10.1016\/j.semperi.2024.152009_bib0083","series-title":"About CAPTA: A legislative History","year":"2019"},{"key":"10.1016\/j.semperi.2024.152009_bib0084","unstructured":"Administration for Children and Families. Program instruction: Guidance On Amendments Made to the Child Abuse Prevention and Treatment Act (CAPTA) By Public Law 114-198, the Comprehensive Addiction and Recovery Act of 2016. January 17, 2017."},{"key":"10.1016\/j.semperi.2024.152009_bib0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.childyouth.2019.01.042","article-title":"Planning for safe care or widening the net?: A review and analysis of 51 states\u2019 CAPTA policies addressing substance-exposed infants","volume":"99","author":"Lloyd","year":"2019","journal-title":"Child Youth Serv Rev"},{"key":"10.1016\/j.semperi.2024.152009_bib0086","series-title":"Pregnancy and drugs: Legal significance For Child Abuse\/Child Neglect","year":"2023"},{"key":"10.1016\/j.semperi.2024.152009_bib0087","article-title":"Pregnancy and drugs: civil commitment","author":"Department of Health","year":"2023","journal-title":"National Institute on Alcohol Abuse and Alcoholism"},{"key":"10.1016\/j.semperi.2024.152009_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104380","article-title":"Punitive legal responses to prenatal drug use in the United States: A survey of state policies and systematic review of their public health impacts","volume":"126","author":"Bruzelius","year":"2024","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.semperi.2024.152009_bib0089","unstructured":"If When How: Lawyering for Reproductive Justice. (2024c, February 29). Prenatal drug exposure: capta reporting requirements for medical professionals. https:\/\/ifwhenhow.org\/wp-content\/uploads\/2024\/02\/2024-Prenatal-Drug-Exposure-CAPTA-Reporting-Requirements-for-Medical-Professionals.pdf."},{"issue":"3","key":"10.1016\/j.semperi.2024.152009_bib0090","first-page":"733","article-title":"Mutual deference between hospitals and courts: how mandated reporting from medical providers harms families","volume":"11","author":"Presler","year":"2021","journal-title":"Colum J Race Law"},{"issue":"Suppl 1","key":"10.1016\/j.semperi.2024.152009_bib0091","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s10995-023-03672-x","article-title":"Prescribed and penalized: the detrimental impact of mandated reporting for prenatal utilization of medication for opioid use disorder","volume":"27","author":"Work","year":"2023","journal-title":"Matern Child Health J"},{"issue":"10","key":"10.1016\/j.semperi.2024.152009_bib0092","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1542\/hpeds.2022-006562","article-title":"Novel implementation of state reporting policy for substance-exposed infants","volume":"12","author":"Lloyd Sieger","year":"2022","journal-title":"Hosp Pediatr"},{"key":"10.1016\/j.semperi.2024.152009_bib0093","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1056\/NEJMp2111378","article-title":"The 2021 reauthorization of CAPTA \u2014 letting public health lead","volume":"385","author":"Lloyd Sieger","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.semperi.2024.152009_bib0094","first-page":"1","article-title":"Pregnant women and substance use: fear, stigma, and barriers to care","volume":"3","author":"Stone","year":"2015","journal-title":"Health and Justice"},{"issue":"3","key":"10.1016\/j.semperi.2024.152009_bib0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10995-010-0594-7","article-title":"Complex calculations: How drug use during pregnancy becomes a barrier to prenatal care","volume":"15","author":"Roberts","year":"2011","journal-title":"Matern Child Health J"},{"issue":"10","key":"10.1016\/j.semperi.2024.152009_bib0096","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1055\/s-0032-1316439","article-title":"Inadequate prenatal care utilization and risks of infant mortality and poor birth outcome: a retrospective analysis of 28,729,765 U.S. deliveries over 8 years","volume":"29","author":"Partridge","year":"2012","journal-title":"Am J Perinatol"},{"issue":"5","key":"10.1016\/j.semperi.2024.152009_bib0097","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1377\/hlthaff.2021.01755","article-title":"State policies that treat prenatal substance use as child abuse or neglect fail to achieve their intended goals","volume":"41","author":"Maclean","year":"2020","journal-title":"Health Aff (Millwood)"},{"issue":"12","key":"10.1016\/j.semperi.2024.152009_bib0098","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1111\/add.15582","article-title":"Outcomes associated with the use of medications for opioid use disorder during pregnancy","volume":"116","author":"Krans","year":"2021","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.semperi.2024.152009_bib0099","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11414-011-9247-x","article-title":"Universal screening for alcohol and drug use and racial disparities in child protective services reporting","volume":"39","author":"Roberts","year":"2012","journal-title":"J Behav Health Serv Res"},{"issue":"3","key":"10.1016\/j.semperi.2024.152009_bib0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.whi.2010.02.003","article-title":"Women's perspectives on screening for alcohol and drug use in prenatal care","volume":"20","author":"Roberts","year":"2010","journal-title":"Women's Health Issues"},{"issue":"8","key":"10.1016\/j.semperi.2024.152009_bib0101","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jamapediatrics.2020.1027","article-title":"Association between state-level criminal justice\u2013focused prenatal substance use policies in the us and substance use\u2013related foster care admissions and family reunification","volume":"174","author":"Sanmartin","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.semperi.2024.152009_bib0102","first-page":"150","article-title":"Test or Talk: Empiric Bias and Epistemic Injustice","volume":"140","author":"Terplan","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.semperi.2024.152009_bib0103","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3476(89)80860-1","article-title":"Drug screening of meconium in infants of drug-dependent mothers: An alternative to urine testing","volume":"115","author":"Ostrea","year":"1989","journal-title":"J Pediat"},{"key":"10.1016\/j.semperi.2024.152009_bib0104","series-title":"Rockville (MD): Substance Abuse and Mental Health Services Administration (US)","article-title":"A guide to substance abuse services for primary care clinicians","year":"1997"},{"issue":"Suppl 1","key":"10.1016\/j.semperi.2024.152009_bib0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s10995-023-03672-x","article-title":"Prescribed and penalized: the detrimental impact of mandated reporting for prenatal utilization of medication for opioid use disorder","volume":"27","author":"Work","year":"2023","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.semperi.2024.152009_bib0106","unstructured":"American Medical Association and Manatt Health. (2024a, January 19). Improving access to care for pregnant and postpartum people with opioid use disorder. https:\/\/end-overdose-epidemic.org\/wp-content\/uploads\/2024\/02\/AMA-Manatt-2024-Improving-Access-to-Care-Pregnant-Parenting-People-with-SUD.pdf."},{"issue":"11","key":"10.1016\/j.semperi.2024.152009_bib0107","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1542\/neo.23-10-e788","article-title":"Equity in Policies Regarding Urine Drug Testing in Infants","volume":"23","author":"Murosko","year":"2022","journal-title":"Neoreviews"},{"issue":"1","key":"10.1016\/j.semperi.2024.152009_bib0108","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11414-011-9247-x","article-title":"Universal Screening for Alcohol and Drug Use and racial disparities in child Protective Services Reporting","volume":"39","author":"Roberts","year":"2012","journal-title":"J Behav Health Serv Res"},{"issue":"141\u2013147","key":"10.1016\/j.semperi.2024.152009_bib0109","first-page":"e142","article-title":"Hospital variation in child protection reports of substance exposed infants","volume":"208","author":"Rebbe","year":"2019","journal-title":"J Pediatr"},{"issue":"11","key":"10.1016\/j.semperi.2024.152009_bib0110","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1089\/jwh.2023.0822","article-title":"Reporting perinatal substance use to child protective services: obstetric provider perspectives on the impact on care","volume":"33","author":"Kaufman","year":"2024","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.semperi.2024.152009_bib0111","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1542\/hpeds.2022-006837","article-title":"Increasing awareness is needed among pediatric hospitalists about prenatal substance exposure: policy, advocacy, and clinical care","volume":"12","author":"Ostfeld-Johns","year":"2022","journal-title":"Hosp Pediatr"},{"key":"10.1016\/j.semperi.2024.152009_bib0112","unstructured":"Yale New Haven Children's Hospital. (n.d.-b). Yale New Haven Children's hospital: Clinical Pathways. Yale New Haven Children's Hospital | Clinical Pathways. https:\/\/www.ynhh.org\/childrens-hospital\/medical-professionals\/clinical-pathways."}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000524001447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000524001447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T17:20:44Z","timestamp":1739035244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000524001447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0146000524001447"],"URL":"https:\/\/doi.org\/10.1016\/j.semperi.2024.152009","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-natal and post-natal screening and testing in neonatal abstinence syndrome","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semperi.2024.152009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152009"}}